Skip to content

Gross margin at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp
Stryker logo
StrykerSYK
63.8%-0.1pp
IAR
Integra LifeSciencesIART
51.9%-1.6pp
Solventum logo
SolventumSOLV
53.7%-0.9pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
70.7%+3.6pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
62.3%+1.1pp

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

Based on trailing twelve months.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s gross margin?
Sanara MedTech Inc. (SMTI) reported gross margin of 92.9% in Q1 2026.
How has Sanara MedTech Inc.'s gross margin changed year-over-year?
Sanara MedTech Inc.'s gross margin increased by 1.9% year-over-year, from 91.2% to 92.9%.
What is the long-term trend for Sanara MedTech Inc.'s gross margin?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s gross margin has grown at a 0.3% compound annual growth rate (CAGR), from 91.3% to 92.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.